Perifosine: Update on a novel Akt inhibitor
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11912-009-0016-4.pdf
Reference63 articles.
1. Bai X, Ma D, Liu A, et al.: Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science 2007, 318:977–980.
2. LoPiccolo J, Granville CA, Gills JJ, Dennis PA: Targeting Akt in cancer therapy. Anticancer Drugs 2007, 18:861–874.
3. Catley L, Hideshima T, Chauhan D, et al.: Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma model. Exp Hematol 2007, 35:1038–1046.
4. Chiarini F, Del Sole M, Mongiorgi S, et al.: The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrugresistant human T-acute leukemia cells by a JNK-dependent mechanism. Leukemia 2008, 22:1106–1116.
5. Hideshima T, Catley L, Yasui H, et al.: Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Blood 2006, 107:4053–4062.
Cited by 206 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of UCHL3 in health and disease;Biochemical and Biophysical Research Communications;2024-11
2. The combination of temozolomide and perifosine synergistically inhibit glioblastoma by impeding DNA repair and inducing apoptosis;Cell Death Discovery;2024-07-08
3. Wogonin preconditioning of MSCs improved their therapeutic efficiency for colitis through promoting glycolysis;Inflammopharmacology;2024-05-16
4. MST2 Acts via AKT Activity to Promote Neurite Outgrowth and Functional Recovery after Spinal Cord Injury in Mice;Molecular Neurobiology;2024-04-06
5. Interfering with the AKT/mTOR/STAT3/ID1 signaling axis with usenamine A restrains the proliferative and invasive potential of human hepatocellular carcinoma cells;Chinese Medicine;2024-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3